tradingkey.logo

DaVita Inc

DVA
View Detailed Chart
140.830USD
-8.390-5.62%
Close 02/06, 16:00ETQuotes delayed by 15 min
9.65BMarket Cap
14.00P/E TTM

DaVita Inc

140.830
-8.390-5.62%
Intraday
1m
30m
1h
D
W
M
D

Today

-5.62%

5 Days

+28.80%

1 Month

+22.76%

6 Months

+10.19%

Year to Date

+23.96%

1 Year

-18.16%

View Detailed Chart

TradingKey Stock Score of DaVita Inc

Currency: USD Updated: 2026-02-06

Key Insights

DaVita Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 27 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 150.51.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

DaVita Inc's Score

Industry at a Glance

Industry Ranking
27 / 75
Overall Ranking
147 / 4521
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

DaVita Inc Highlights

StrengthsRisks
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Fairly Valued
The company’s latest PE is 14.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 36.29M shares, increasing 0.04% quarter-over-quarter.
Held by Scotia Canadian Dividend Fund
Star Investor Scotia Canadian Dividend Fund holds 4.93K shares of this stock.

Analyst Rating

Based on 10 analysts
Hold
Current Rating
150.514
Target Price
+0.87%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

DaVita Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

DaVita Inc Info

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Ticker SymbolDVA
CompanyDaVita Inc
CEORodriguez (Javier J)
Websitehttps://www.davita.com/
KeyAI